Inflammatory Markers Are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade
figureposted on 18.03.2021, 11:56 authored by Adis journals on behalf of, Guillermo Carvajal Alegria, Divi Y. K Cornec, Yves Renaudineau, Alain Saraux, Valérie Devauchelle-Pensec
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.